JDRF T1D Fund — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Immunocoreimmunocore.cominNASDAQ: IMCRJul 2022
BiotechAbingdon, Oxfordshire
Brian Di Donato(Chief Financial Officer)John Bell(Chairman of the Board of Directors)Robert Perez(Director)David Berman(Head of Research and Development)Tina St. Leger(Chief Human Resources Officer)Peter Ratcliffe(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.